In view of the fact that among the specimens we collected, 15 patients experienced relapses even after using gemcitabine, we examined the expression level of NXPH4 between the relapse tissue and the initial tumor tissue and found that NXPH4 was significantly elevated at the level of mRNA and protein when the patients experienced relapses. The gene discussed is NXPH4; the disease is neoplasm.